Literature DB >> 6624542

Plasma high-density lipoproteins and liver lipids and proteins in man. Relation to hepatic histology and microsomal enzyme induction.

P V Luoma, M J Savolainen, E A Sotaniemi, R O Pelkonen, A J Arranto, C Ehnholm.   

Abstract

The association of high-density lipoproteins (HDL) in plasma with liver lipids and proteins was investigated in 28 subjects with diagnostic liver biopsy. Lipids and proteins were evaluated in relation to hepatic histology and microsomal enzyme induction, assessed by liver cytochrome P-450. Moderate-severe hepatic parenchymal changes were associated with low liver phospholipids, protein and cytochrome P-450, low plasma HDL cholesterol (HDL-C), and high hepatic triglycerides. Liver microsomal induction accompanying anticonvulsant therapy was associated with high liver phospholipids and protein, high plasma HDL-C, apoproteins A-I and A-II, and high HDL-C/total cholesterol (T-C) ratio. HDL-C, A-I and the HDL-C/T-C ratio were directly proportional to liver phospholipids, protein and cytochrome P-450, inversely related to hepatic triglycerides. Increases in hepatic phospholipids and protein, characteristic of microsomal induction, may lead to the elevation of plasma HDL apoprotein and HDL-C levels and HDL-C/T-C ratios, and thus reduce the risk of coronary heart disease.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6624542     DOI: 10.1111/j.0954-6820.1983.tb08580.x

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN: 0001-6101


  5 in total

Review 1.  Gene activation regresses atherosclerosis, promotes health, and enhances longevity.

Authors:  Pauli V Luoma
Journal:  Lipids Health Dis       Date:  2010-07-06       Impact factor: 3.876

2.  Relationship between lipid composition and drug metabolizing capacity of human liver.

Authors:  M J Savolainen; A J Arranto; I E Hassinen; P V Luoma; R O Pelkonen; E A Sotaniemi
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

Review 3.  Cytochrome P450 and gene activation--from pharmacology to cholesterol elimination and regression of atherosclerosis.

Authors:  Pauli V Luoma
Journal:  Eur J Clin Pharmacol       Date:  2008-07-17       Impact factor: 2.953

Review 4.  Gene-activation mechanisms in the regression of atherosclerosis, elimination of diabetes type 2, and prevention of dementia.

Authors:  P V Luoma
Journal:  Curr Mol Med       Date:  2011-07       Impact factor: 2.222

Review 5.  Elimination of endoplasmic reticulum stress and cardiovascular, type 2 diabetic, and other metabolic diseases.

Authors:  Pauli V Luoma
Journal:  Ann Med       Date:  2012-08-28       Impact factor: 4.709

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.